Abstract
Purpose
To appraise the diagnostic performance of magnetic resonance imaging-guided percutaneous coaxial cutting needle biopsy of pancreatic lesions using a 0.4-T open magnetic resonance imaging scanner with optical tracking navigation.
Materials and Methods
This retrospective study included 158 patients who underwent magnetic resonance imaging-guided pancreatic lesion biopsy procedures from May 2019 to December 2020. Two to four specimens were collected from each patient. Pathological diagnosis and clinical follow-ups were conducted to establish the final diagnosis. The procedures were evaluated for sensitivity, specificity, positive and negative predictive values, diagnostic accuracy, and complications. The Cardiovascular and Interventional Radiological Society of Europe guidelines were used to classify complications.
Results
Biopsy pathology revealed 139 pancreatic tumor malignancies and 19 benign pancreatic lesions. Finally, 151 patients were diagnosed with pancreatic malignancy and 7 with benign disease confirmed by surgery, re-biopsy, and clinical follow-up. The sensitivity, specificity, positive and negative predictive value, and accuracy for diagnosis of pancreatic diseases were 92.1%, 100%, 100%, 36.8%, and 92.4%, respectively. The biopsy accuracy was significantly related to the size (≤ 2 cm, 76.2%; 2–4 cm, 94.0%; > 4 cm, 96.2%, P = .02) and not the lesion's location (head of pancreas, 90.7%; neck of pancreas, 88.9%; body of pancreas, 94.3%; tail of pancreas, 96.7%, P = .73). Minor complications included two patients experiencing mild abdominal pain and two with a minor occurrence of hemorrhage.
Conclusions
Percutaneous magnetic resonance imaging-guided pancreatic lesion biopsy combined with optical navigation has high diagnostic accuracy and is safe for clinical practice.
Level of Evidence Level 4, Case-series.
Similar content being viewed by others
References
Le Grazie M, Conti Bellocchi MC, Bernardoni L, et al. Diagnostic yield of endoscopic ultrasound-guided tissue acquisition of solid pancreatic lesions after inconclusive percutaneous ultrasound-guided tissue acquisition. Scand J Gastroenterol. 2020;55(9):1108–13.
Xin Y, Yang Y, Chen Y, Wang Y, Cao XJ, Zhou X. Safety and efficacy of ultrasound-guided percutaneous coaxial core biopsy of pancreatic lesions: a retrospective study. J Ultrasound. 2021;24(3):269–77.
Su YY, Liu YS, Chao YJ, Chiang NJ, Yen CJ, Tsai HM. Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors. J Clin Med. 2019;8(10)
Liu C, Wang L, He X, et al. 1.0T MR-guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis. J Magn Reson Imaging. 2018;48(2):382–8.
Okasha HH, Naga MI, Esmat S, et al. Endoscopic ultrasound-guided fine needle aspiration versus percutaneous ultrasound-guided fine needle aspiration in diagnosis of focal pancreatic masses. Endosc Ultrasound. 2013;2(4):190–3.
Sugiura R, Kuwatani M, Hirata K, et al. Effect of pancreatic mass size on clinical outcomes of endoscopic ultrasound-guided fine-needle aspiration. Dig Dis Sci. 2019;64(7):2006–13.
Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018;24(19):2047–60.
Huang Y, Shi J, Chen YY, Li K. Ultrasound-guided percutaneous core needle biopsy for the diagnosis of pancreatic disease. Ultrasound Med Biol. 2018;44(6):1145–54.
Clasen S, Rempp H, Boss A, et al. MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness. J Vasc Interv Radiol. 2011;22(6):762–70.
He X, Liu M, Liu C, et al. Real-time MR-guided brain biopsy using 1.0-T open MRI scanner. Eur Radiol. 2019;29(1):85–92.
Liu S, Ren R, Liu M, Lv Y, Li B, Li C. MR imaging-guided percutaneous cryotherapy for lung tumors: initial experience. J Vasc Interv Radiol. 2014;25(9):1456–62.
Cazzato RL, De Marini P, Auloge P, et al. Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years. Eur Radiol. 2021;31(2):580–90.
Liu M, Sequeiros RB, Xu Y, et al. MRI-guided percutaneous transpedicular biopsy of thoracic and lumbar spine using a 0.23t scanner with optical instrument tracking. J Magn Reson Imaging. 2015;42(6):1740–6.
Garnon J, Ramamurthy N, Caudrelier JJ, et al. MRI-guided percutaneous biopsy of mediastinal masses using a large bore magnet: technical feasibility. Cardiovasc Intervent Radiol. 2016;39(5):761–7.
Das CJ, Goenka AH, Srivastava DN. MR-guided abdominal biopsy using a 1.5-Tesla closed system: a feasibility study. Abdom Imaging. 2010;35(2):218–23.
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6.
Kariniemi J, Blanco Sequeiros R, Ojala R, Tervonen O. MRI-guided abdominal biopsy in a 0.23-T open-configuration MRI system. Eur Radiol. 2005;15(6):1256–62.
Zangos S, Eichler K, Wetter A, et al. MR-guided biopsies of lesions in the retroperitoneal space: technique and results. Eur Radiol. 2006;16(2):307–12.
Kahriman G, Ozcan N, Dogan S, Ozmen S, Deniz K. Percutaneous ultrasound-guided core needle biopsy of solid pancreatic masses: results in 250 patients. J Clin Ultrasound. 2016;44(8):470–3.
Hartwig W, Schneider L, Diener MK, Bergmann F, Büchler MW, Werner J. Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg. 2009;96(1):5–20.
Hsu MY, Pan KT, Chen CM, et al. CT-guided percutaneous core-needle biopsy of pancreatic masses: comparison of the standard mesenteric/retroperitoneal versus the trans-organ approaches. Clin Radiol. 2016;71(6):507–12.
Stella SF, Van Borsel M, Markose G, Nair SB. Image-guided percutaneous biopsy for pancreatic lesions: 10-year experience in a tertiary cancer center. Can Assoc Radiol J. 2019;70(2):199–203.
Gui Y, Dai M, Meng Z, et al. Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions. Chin Med J (Engl). 2021;135(4):426–32.
Acknowledgements
The authors would like to thank Mengqi Yan for her excellent technical support.
Funding
This work was supported by Shanghai Science and Technology Innovation Fund (19441907000).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Xuebin Zhang, Fangqin Zhang, Guangxin Jin, Min Ding, Mengjun Dai, and Jie Zhang. The first draft of the manuscript was written by Fangqin Zhang, and all authors commented on previous versions of the manuscript. Fangqin Zhang and Guangxin Jin contributed equally to this work. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Consent for Publication
For this type of study, formal consent is not required.
Ethical Approval
For this type of study, formal consent is not required.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, F., Jin, G., Dai, M. et al. Percutaneous Magnetic Resonance Imaging-Guided Coaxial Cutting Needle Biopsy of Pancreatic Lesions: Diagnostic Accuracy and Safety. Cardiovasc Intervent Radiol 46, 1603–1609 (2023). https://doi.org/10.1007/s00270-023-03485-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-023-03485-z